Charles Schwab Investment Management Inc Gsk PLC Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $38.6 Million - $45 Million	-1,125,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $11.3 Million - $13.3 Million	332,500 Added 41.96%	1,125,000 $41.4 Million
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $476,375 - $537,375	12,500 Added 1.6%	792,500 $29.8 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $2.27 Million - $2.61 Million	-60,000 Reduced 7.14%	780,000 $31.8 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $1.2 Million - $1.81 Million	37,100 Added 4.62%	840,000 $31.8 Million
Q4 2019 Feb 07, 2020	SELL	$42.0 - $48.25 $1.56 Million - $1.79 Million	-37,100 Reduced 4.42%	802,900 $37.7 Million
Q3 2019 Nov 08, 2019	BUY	$40.46 - $43.52 $809,200 - $870,400	20,000 Added 2.44%	840,000 $35.9 Million
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $31.6 Million - $35 Million	820,000 New	820,000 $34.3 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.